TABLE 1

Patient-, Provider-, and Practice-Level Factors Associated With Hypertension Screening in Pediatric Preventive Visits

CharacteristicNo. of Sampled Preventive Visits (N = 15 334)Weighted Proportion of Visits With Hypertension Screening, %P2)OR (95% CI) for Hypertension Screening
Time, per 2 y<.00011.3 (1.2–1.4)
Age group, y<.0001
 3–75353561.00
 8–123463671.5 (1.3–1.8)
 13–186518772.6 (2.2–3.0)
Gender.01
 Male7508651.00
 Female7826681.0 (0.9–1.2)
Race/ethinicitya.53
 Non-Hispanic white6343691.00
 Non-Hispanic black3635690.9 (0.7–1.2)
 Hispanic3668660.9 (0.7–1.2)
 Other1043661.0 (0.7–1.4)
US census region.03
 Northeast5,5.2681.00
 Midwest3720701.1 (0.8–1.4)
 South3294670.9 (0.7–1.2)
 West2818610.8 (0.5–1.0)
Specialtyb<.0001
 Pediatric preventive care3653671.00
 Family practice1078751.1 (0.8–1.5)
 Internal medicine84690.7 (0.4–1.3)
 Specialists1645590.4 (0.3–0.5)
Setting.11
 Physician office6460671.00
 Outpatient department8874701.1 (0.9–1.3)
Overweight/obesity diagnosed?<.0001
 No14 629661.00
 Yes705842.2 (1.4–3.5)
Length of visit, minb<.0001
 ≤153263631.00
 >153358701.3 (1.0–1.7)
EMRb,c.02
 No2502761.00
 Yes2351700.8 (0.6–1.1)
Insurance typea.63
Nonprivate879867
Private579066
Metropolitan statistical area.83
Metropolitan13 64068
Nonmetropolitan101668
  • a Raw N do not sum to 15 334 because of missing data.

  • b Data are for NAMCS (offices) only. ORs are estimated from a separate model by using data only from the NAMCS surveys.

  • c Data were available only for 2003–2009.